Black women & midlife
What we know, what's still thin, and what isn't ours to hold alone. An open page, with room for Black contributors to shape what comes next.
The research gap is real. The evidence that does exist (SWAN, fibroids, cardiometabolic risk, MHT access) is worth naming honestly. The first-person writing isn't ours to write, and we'd rather say so than fake it.
Before we start
Nila's lead editorial voice is currently white-led, not ghost-written. We can hold the research honestly and link the evidence, and we do. We can't write the lived experience of Black women in midlife, and we won't pretend to. This page is the welcome and the signpost; the deeper writing is one we're actively looking for Black writers, reviewers and a lead voice to shape, paid and credited, with editorial say on framing.
One thing worth naming directly: this is the deepest named hub on the site right now because it's the group we currently have the most evidence to write honestly about (SWAN is the gold-standard cohort and it oversampled Black women), and the one we're furthest along in commissioning paid contributors for. That isn't Black women being treated as the exemplar racialized reader. The same offer — a named hub with a lead voice, paid contributors and editorial say — stands for any other group whose experience the site isn't yet holding well. If that's you, ask us. The wider research-gap stance lives on research gaps.
The wider evidence on ethnicity and menopause (SWAN on vasomotor duration, FRAX caveats, dermatology gaps, cardiometabolic timing, practitioner concordance) lives on the women of colour pathway. This page holds what's specifically Black-women shaped on top of that, and names the gaps on purpose.
What sits specifically here
Three things the wider page doesn't cover on its own.
Fibroids, MHT access, and the weight of medical history. The vasomotor, bone and dermatology pieces are on the wider women of colour page; we'd rather link them than reprint them.
Fibroids
Fibroids show up earlier, larger, and more often
Uterine fibroids are roughly two to three times more common in Black women, tend to appear earlier, and are more likely to cause heavy bleeding, pelvic pain, and hysterectomy by midlife. They also complicate the perimenopause picture, heavy bleeding gets blamed on fibroids when hormones are also involved, or blamed on hormones when fibroids are the actual driver. A pelvic ultrasound before any treatment decision is reasonable to ask for.
MHT access, the gap inside the gap
Black women are offered hormone therapy less often
Multiple US studies have found Black women are less likely to be offered menopausal hormone therapy (MHT/HRT) than white women with comparable symptoms, and more likely to be steered toward antidepressants or 'lifestyle' first. The 2002 Women's Health Initiative scare hit prescribing across the board, but the recovery hasn't been even. If your symptoms are significant and MHT hasn't been raised, raising it yourself is reasonable. The treatments page covers what's on the menu.
Trust, earned and unearned
The history with the medical system isn't ancient
Henrietta Lacks, the Tuskegee study, J. Marion Sims, the maternal mortality numbers that still don't move much when income is controlled for, all of that is a real reason a perimenopause appointment can carry weight a doctor doesn't see. We've written a trauma-informed care page about how past medical appointments shape current ones, with scripts, witnesses, and what to write down. It isn't the whole answer, but it's a start.
Where the substance lives
Pages worth reading with this lens.
Hot flashes
Vasomotor pathway
Read with SWAN in mind. If your flashes are earlier, longer or louder than the page describes, you are the data point the older studies didn't capture. The treatment menu applies the same.
ReadWider lens
Women of colour & midlife
The broader page covering the research bias across ethnicities, plus the variations that are evidenced (vasomotor by group, FRAX caveats, dermatology gaps).
ReadWhat's on the menu
Treatments primer
MHT, non-hormonal Rx, vaginal estrogen, bone meds, in plain language. The medications work the same way regardless of ethnicity. The conversation about which ones for you is what changes.
ReadBefore the appointment
When past medical care makes appointments hard
Scripts, witnesses, what to bring, what to write down. Written for anyone the medical system has burned, with specific notes for women of colour.
ReadBone & heart numbers
Bone, joint and muscle
FRAX and most cardiovascular risk calculators were built on narrow populations and adjusted afterwards. The page anchors on what actually moves the dial, strength training, vitamin D, the meds when needed.
ReadFind a practitioner
Doctors and specialists
Filter the directory by location and area of focus. If cultural concordance matters to you, that's a legitimate criterion, and the community can tell you who has actually been good.
ReadWhat's missing, named on purpose
The work this page is openly asking for help with.
Lived-experience writing
First-person essays from Black women in midlife
The site has plenty of explainer writing. What it does not have, and won't until Black writers shape it, is sustained first-person writing on perimenopause in Black bodies and Black lives, from women who are living it. That's the gap we most want to fill first.
A reviewed fibroid pathway
A standalone fibroid + perimenopause guide
Heavy bleeding, fibroids, and hormonal change tangle together by midlife. A clear, evidence-graded pathway that holds all three at once, reviewed by a Black OB-GYN or fibroid specialist, would do real work. It isn't on the site yet because we want to commission it rather than guess.
Directory depth
Black menopause-trained doctors and therapists
Our practitioner directory is open to all, but the listings in any specialty thin out fast when you filter for Black practitioners with menopause training in a given city. We're working on this, slowly and honestly. If you know good people, the directory has a 'recommend a practitioner' link.
"Median vasomotor symptom duration: 10.1 years for Black women, 6.5 years for white women." The older studies didn't capture the second number because they barely sampled the first.
References & further reading
Evidence, reading, and the history that sits behind it.
The pieces we lean on when this page makes a claim. Two clinical papers, two epidemiology pieces, and two history references — because the trust point isn't rhetorical.
Evidence we cite
Duration of menopausal vasomotor symptoms over the menopause transition
Avis et al. — JAMA Intern Med, 2015 (SWAN)
The SWAN paper that put numbers on what Black women had been saying for years: median vasomotor symptom duration of 10.1 years for Black participants, against 6.5 for white. The single most-cited piece of evidence on this page.
VisitRisks and benefits of estrogen plus progestin in healthy postmenopausal women
Writing Group for the WHI Investigators — JAMA, 2002
The Women's Health Initiative paper that crashed MHT prescribing worldwide. The follow-up re-analyses softened the conclusions but the recovery in prescribing was never even across racial groups.
VisitEpidemiology of uterine fibroids: a systematic review
Stewart et al. — Am J Obstet Gynecol, 2013
The reference review on fibroid prevalence — confirms the two-to-three-times higher cumulative incidence in Black women, earlier age at first diagnosis, and larger fibroid burden by midlife.
VisitRacial and ethnic differences in menopausal hormone therapy use
Manson, Crandall et al. — Ann Intern Med, 2023
Recent analysis confirming that, controlling for symptom severity and contraindications, Black and Hispanic women are still offered and prescribed MHT at significantly lower rates than white women.
VisitReading & context
Menopause and the Black community
Dr Nighat Arif — The Menopause Charity
Plain-language piece by a British-Pakistani GP and menopause specialist on what Black and South Asian women face in the UK menopause system and how to push for the conversation.
VisitBlack Women's Health Imperative — menopause hub
BWHI
The longest-running US Black women's health organisation. Their menopause writing is one of the few places that holds clinical content and lived experience on the same page.
VisitThe Immortal Life of Henrietta Lacks
Rebecca Skloot — Crown, 2010
Context for the 'history with the medical system isn't ancient' point. Reads as a biography; functions as a primer on consent, race and the cell lines half of modern medicine is built on.
VisitThe Tuskegee Syphilis Study, 1932–1972
US Centers for Disease Control
The CDC's own account of the 40-year study that withheld treatment from Black men with syphilis. Useful primary-source link when someone asks why the 'trust earned and unearned' framing isn't melodramatic.
VisitWrite for this page
We're looking for Black writers, reviewers and a lead voice for this work.
Paid at standard editorial rates, credited by name, with real editorial say on framing, scope and language. We're particularly interested in first-person essays, a reviewed fibroid + perimenopause pathway, and a lead voice to hold this hub over time. If any of that is you, or someone you know, the door is open.
The short version
Hold the evidence honestly. Don't speak for the lived experience. Pay the people whose story it actually is to tell. Leave the door open.
If a page on Nila uses framing that lands wrong for you, please tell us — the contact link in the footer goes to a real inbox we read.